BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29224003)

  • 21. Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.
    Jewett A; Bonavida B
    J Clin Immunol; 1995 Jan; 15(1):35-44. PubMed ID: 7759599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
    LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
    FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.
    Biedroń M; Rybka J; Wróbel T; Prajs I; Poręba R; Kuliczkowski K
    Med Oncol; 2015 Aug; 32(8):219. PubMed ID: 26187179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-G modulates immune responses by diverse receptor interactions.
    Hofmeister V; Weiss EH
    Semin Cancer Biol; 2003 Oct; 13(5):317-23. PubMed ID: 14708711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.
    Du L; Xiao X; Wang C; Zhang X; Zheng N; Wang L; Zhang X; Li W; Wang S; Dong Z
    Cancer Sci; 2011 Jul; 102(7):1272-80. PubMed ID: 21466615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8
    Dumont C; Jacquier A; Verine J; Noel F; Goujon A; Wu CL; Hung TM; Desgrandchamps F; Culine S; Carosella ED; Rouas-Freiss N; LeMaoult J
    Cancer Immunol Res; 2019 Oct; 7(10):1619-1632. PubMed ID: 31451484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural Killer Cell Inhibition by HLA-E Molecules on Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelial Cells.
    Sugita S; Makabe K; Iwasaki Y; Fujii S; Takahashi M
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1719-1731. PubMed ID: 29610856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-G1, but Not HLA-G3, Suppresses Human Monocyte/Macrophage-mediated Swine Endothelial Cell Lysis.
    Eguchi H; Maeda A; Lo PC; Matsuura R; Esquivel EL; Asada M; Sakai R; Nakahata K; Yamamichi T; Umeda S; Deguchi K; Ueno T; Okuyama H; Miyagawa S
    Transplant Proc; 2016 May; 48(4):1285-7. PubMed ID: 27320605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis.
    Bylińska A; Wilczyńska K; Malejczyk J; Milewski Ł; Wagner M; Jasek M; Niepiekło-Miniewska W; Wiśniewski A; Płoski R; Barcz E; Roszkowski P; Kamiński P; Malinowski A; Wilczyński JR; Radwan P; Radwan M; Kuśnierczyk P; Nowak I
    Mol Genet Genomics; 2018 Jun; 293(3):601-613. PubMed ID: 29234882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
    Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
    Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
    Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
    Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses.
    Naji A; Menier C; Morandi F; Agaugué S; Maki G; Ferretti E; Bruel S; Pistoia V; Carosella ED; Rouas-Freiss N
    J Immunol; 2014 Feb; 192(4):1536-46. PubMed ID: 24453251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of Cytomegalovirus on Expression of HLA-G and its Ligand KIR2DL4 by Human Peripheral Blood Leucocyte Subsets.
    Albayati Z; Alyami A; Alomar S; Middleton D; Bonnett L; Aleem S; Flanagan BF; Christmas SE
    Scand J Immunol; 2017 Nov; 86(5):396-407. PubMed ID: 28817184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells.
    Xing R; Li L; Chen L; Gao Z; Wang H; Li W; Cui J; Tian G; Liang Q; Yu J; Sung JJ; Luo G; Gao H; Xu X; Yang H; Wang J; Zhang X; Wang JM; Huang J; Yu Y; Wang J; Lu Y
    Oncogene; 2016 May; 35(20):2584-91. PubMed ID: 26364607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors.
    Fu B; Zhou Y; Ni X; Tong X; Xu X; Dong Z; Sun R; Tian Z; Wei H
    Immunity; 2017 Dec; 47(6):1100-1113.e6. PubMed ID: 29262349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion.
    Bae S; Oh K; Kim H; Kim Y; Kim HR; Hwang YI; Lee DS; Kang JS; Lee WJ
    Immunobiology; 2013 Aug; 218(8):1026-33. PubMed ID: 23434435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing.
    Schmitt J; Eckardt S; Schlegel PG; Sirén AL; Bruttel VS; McLaughlin KJ; Wischhusen J; Müller AM
    Mol Med; 2015 Mar; 21(1):185-96. PubMed ID: 25811991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.